UK markets open in 3 hours 30 minutes

Aerie Pharmaceuticals, Inc. (AERI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.26+0.22 (+1.78%)
At close: 4:00PM EST

12.26 0.00 (0.00%)
After hours: 4:18PM EST

Sign in to post a message.
  • S
    Stephen
    See my earlier posts below. Did anyone else listen to the conference call and how not one of the analysts asked the tough questions of management? Why didn't one of the analysts ask why NO ONE in the company has bought their own stock at all time yearly lows???? Hoping that another Pharma or fund takes them out very soon before they finalize a partner agreement in Europe. Management is building a huge empire on a tiny spec of land - way too much overhead - other competitors could do so much better.
  • U
    Uber
    Kopczynski "sold" 30,000 shares at $13.01? Not very good optics here from a co-founder.
  • S
    Stephen
    Take a look at their website and look at how many Vice-Presidents they have!!!! Take a look at their annual report and look at how excessively overpaid their executives are and how no part of their salary is tied to performance and to increasing shareholder value. Take a look at the composition of their board and how a number of them came from the same companies. Take a look at the guy who is chairman of the compensation committee. Take a look at their recent plan for increasing sales - a close friend is the CEO of a regional eye care company - they don't take cold phone calls. Take a look at the insider purchases for the last year - why has no one been buying their own stock down at these prices???? I could go on and on - have seen this many times over the last 40 years of investing - management gets bloated and way overpaid, board is not independent and is good ol boy system, insiders don't buy their own stock - ask yourself why the stock is at all time multi year lows and no one is buying their stock but they continue giving themselves more stock options. Ask yourself why the stock went down to the $9 price (lost of 25% market cap in 2 days) simply based upon the BofA analyst downgrade. I am hoping that a large Pharma or firm takes them out and cleans house. There is a saying that pride comes before a fall - well we have seen this stock fall from $75 to $9 over the last few years. It's time for a change - hopefully the BofA analyst downgrade to sell is the catalyst. As an example, take a look at XERS and how much stock their whole management team purchased over the last 6 months when their stock was down. If management won't even spend one dollar of their own money on their own stock when it is at $9 after overseeing the fall from $75, why would investors or funds be interested????
  • S
    Stephen
    The only reason AERI Management decided to go with the partnership in Japan is so that they can keep paying themselves excessive salaries and keep awarding themselves more stock options. To keep it very simple, AERI's management and board have not purchased one share of their own stock in the last 12 months and their stock is at all time lows. Enough said - that is why the stock is down on the news.
  • U
    Uber
    Well, the Santen partnership puts $50M in AERI's pocket now plus potentially another $99M in sales milestones. That's a lot of dilution that won't be taking place.
  • U
    Uber
    10 sell-side analysts cover AERI and 9 of them are either "buy", or "strong buy". The one guy at Bank of America who was "neutral" goes to "sell" and it tanks the stock by 13%? Interesting.
  • S
    Stephen
    Take a look at their website and look at how many Vice-Presidents they have!!!! Take a look at their annual report and look at how excessively overpaid their executives are and how no part of their salary is tied to performance and to increasing shareholder value. Take a look at the composition of their board and how a number of them came from the same companies. Take a look at the guy who is chairman of the compensation committee. Take a look at their recent plan for increasing sales - a close friend is the CEO of a regional eye care company - they don't take cold phone calls. Take a look at the insider purchases for the last year - why has no one been buying their own stock down at these prices???? I could go on and on - have seen this many times over the last 40 years of investing - management gets bloated and way overpaid, board is not independent and is good ol boy system, insiders don't buy their own stock - ask yourself why the stock is at all time multi year lows and no one is buying their stock but they continue giving themselves more stock options. Ask yourself why the stock went down to the $9 price (lost of 25% market cap in 2 days) simply based upon the BofA analyst downgrade. I am hoping that a large Pharma or firm takes them out and cleans house. There is a saying that pride comes before a fall - well we have seen this stock fall from $75 to $9 over the last few years. It's time for a change - hopefully the BofA analyst downgrade to sell is the catalyst. As an example, take a look at XERS and how much stock their whole management team purchased over the last 6 months when their stock was down. If management won't even spend one dollar of their own money on their own stock when it is at $9 after overseeing the fall from $75, why would investors or funds be interested????
  • U
    Uber
    Seems not to be much of a following here but if anyone is willing to engage, I'd like to know what your long thesis is. My take on the pps is that Mr. market does not want to wait for positive fcf which may be 2-3 years away despite product on the market. Thoughts?
  • D
    David
    They should go Private.... then CEO is now down Over -50% since his last Big purchase a year ago.
  • U
    Uber
    Imagine what AERI would have done today had the market not ben down a grand.
  • D
    David
    Overpaid management, Many of management have very little 'skin-in-the-game', and Sales are growing at a snails pace,... something has got to happen here, in the next 6 months.
  • M
    Mike
    So I see this stock has done worse since the last time I was on here giving free advise to hopefuls wanting to make a fast buck on a ROC inhibitor. Hopefully you all took that advise wisely and got out while you could. So no internal corporate buying of Aeri stock! Not a good sign. My guess is (assuming it hasn't already happened) is that executive management members will start to depart. Very difficult to win any appreciable market share in the glaucoma space with anything but tried and true Prostaglandin drugs. We've seen this over the last 35 years. Sorry to those who lost their #$%$ but you were warned.
  • S
    Stephen
    Direct quote from 4 investment services from today 10/21/20:

    "AERI has not reported any insider buys through the SEC in the past year."

    Again, ask yourself why?????
  • L
    Lance
    way oversold...
  • R
    Rod
    Geesh. Finally, a bit of of reality. FTM EPS of minus $2.88 and AERI is changing hands a at $10.02. I'm thinking $9 per share is still blue sky. Gimme penny prices and I'll start following.
  • Y
    Yahoo Finance Insights
    Aerie Pharmaceuticals reached a 52 Week low at 9.74
  • Y
    Yahoo Finance Insights
    Aerie Pharmaceuticals reached a 52 Week low at 10.10
  • p
    pandey
    heading back to 5
  • p
    pandey
    this stock is taking a hit because analyst at BOA downgraded. something more then that.
  • b
    babikian
    I started following "awesomestokcalerts" (Gooogle it - off course without any space or dash in between the words) and their notifications are better than anyone else.